Brief: Senti Biosciences Q3 Net Income USD -18.126 Million
13/11/2025 21:30
Nov 13 (Reuters) - Senti Biosciences Q3 operating expenses USD 16.948 million. Q3 operating income USD -16.948 million Q3 EPS USD -0.69
Recent news on Senti Biosciences Holdings
See all newsBrief: Senti Biosciences Says Offering 15.97 Million Shares Of Common Stock For Resale By Selling Securityholder
Senti Biosciences Q1 net loss narrows on cost reduction
Brief: Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy
Brief: Senti Biosciences Announces Holding Company Reorganization Effective By April 16, 2026 - SEC Filing
Senti Biosciences Q4 revenue misses analyst estimates